Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom. Haleon plc(LSE:HLN) operates independently of GSK plc as of July 18, 2022.
IPO Year: 2022
Exchange: NYSE
Website: https://www.haleon.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/27/2025 | $13.40 | Neutral → Outperform | BNP Paribas Exane |
| 5/9/2025 | $11.25 | Equal-Weight → Overweight | Morgan Stanley |
| 3/5/2025 | Buy → Hold | HSBC Securities | |
| 1/10/2025 | Overweight → Equal-Weight | Morgan Stanley | |
| 1/8/2025 | Outperform → Mkt Perform | Bernstein | |
| 8/6/2024 | Buy → Neutral | Goldman | |
| 8/6/2024 | Buy | Berenberg | |
| 6/5/2024 | Buy | Berenberg | |
| 4/17/2024 | Buy | HSBC Securities | |
| 12/11/2023 | Buy | Jefferies |
Live Leadership Updates
LONDON, June 24, 2025 /PRNewswire/ -- Haleon (LSE: HLN) (NYSE:HLN) today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025. This appointment follows Franck Riot deciding to leave Haleon after six years in the business. Carl joins Haleon from the Estée Lauder Companies Inc. where he has spent 13 years as Executive Vice President, Global Innovation and Research and Development. Carl previously spent over 20 years at P&G across Home, Health and Beauty Care. Brian McNamara, Haleon's Chief Executive Officer commented: "I am delighted to welcome Carl to Haleon. Carl is a world-renowned leader in R&D, with significant experi
WARREN, N.J., Dec. 2, 2024 /PRNewswire/ -- Haleon, a world-leading consumer health company, is pleased to announce the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for its US business, effective December 1, 2024. In this role, Joe will lead the organization's customer strategy, driving growth and transformation in the US market. Joe brings extensive leadership experience to the role, having spent over 20 years in the FMCG sector and serving in the military. Most recently Joe led Unilever's Walmart business, overseeing the company's largest US customer. In his
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
6-K - Haleon plc (0001900304) (Filer)
Fastest customizable press release news feed in the world
The Freepod® nasal spray pump, globally used with the Otrivin® brand, is now made from 52% bio-based feedstock Aptar Pharma, a global leader in drug delivery and active material science solutions and services, is proud to announce that its Freepod® nasal spray pump - one of the delivery systems for Haleon's Otrivin® brand - is now made with mass balance bio-based resins. This is the first Aptar delivery system using such materials to be commercialized globally. The use of more sustainable renewable plastic resources is a meaningful measure to help reduce the use of fossil-based materials in healthcare primary packaging. This press release features multimedia. View the full release here:
LONDON, June 24, 2025 /PRNewswire/ -- Haleon (LSE: HLN) (NYSE:HLN) today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025. This appointment follows Franck Riot deciding to leave Haleon after six years in the business. Carl joins Haleon from the Estée Lauder Companies Inc. where he has spent 13 years as Executive Vice President, Global Innovation and Research and Development. Carl previously spent over 20 years at P&G across Home, Health and Beauty Care. Brian McNamara, Haleon's Chief Executive Officer commented: "I am delighted to welcome Carl to Haleon. Carl is a world-renowned leader in R&D, with significant experi
Toronto, ON, May 26, 2025 (GLOBE NEWSWIRE) -- With National Smile Day around the corner, new research from Sensodyne, the #1 dentist-recommended brand for sensitive teeth, reveals that more than 80 per cent of Canadians want whiter teeth, but for many, sensitivity and cost are standing in the way. The recent survey in partnership with Harris Poll, showed that 40 per cent have resorted to TikTok trend alternatives like baking soda, activated charcoal and oil pulling to get the results they want, but these often come at a painful cost: nearly half (46 per cent) of users report increased sensitivity. Despite widespread awareness of dentist-administered whitening treatments, only a quart
Forager® AI Platform to Enable Haleon's Scientists to Unlock the Power of Nature for Consumer Health Haleon (LSE: HLN), a global leader in consumer health, and Brightseed, the pioneer in AI-driven discovery of bioactive compounds, announced a new collaboration to advance the discovery of plant-based, small molecules with the potential to improve human health. This partnership will leverage Brightseed's proprietary AI platform, Forager®, as a solution to accelerate scientific insights into the natural world and support Haleon's mission to deliver innovative, science-led health solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/ho
The partnership marks Haleon Canada's first national, full-portfolio sponsorship TORONTO, April 24, 2025 /CNW/ - Canada Soccer and Haleon Canada announced a new multi-year partnership committed to promoting health and wellness on and off the pitch. As part of the deal, Haleon Canada — the makers of well-known brands like Advil, Buckley's, Centrum and Sensodyne — will serve as the Official Consumer Health partner of Canada Soccer and its Men's and Women's National Team programs. Haleon Canada, and its more than 25 brands, will have category exclusivity for Pain Relief, Oral Healthcare, Vitamins, Digestive Health, and Respiratory including cough and cold. The par
Fans can draft their top food and drink picks for a free shot at winning a share of $40,000 in total cash prizes WARREN, N.J., Jan. 9, 2025 /PRNewswire/ -- As hundreds of millions prepare to tune into the biggest day in football, a new survey from TUMS has revealed that 1 in 4 viewers will be focused on the real MVP: the food.* To celebrate gameday foodies, TUMS has teamed up with DraftKings to launch TUMS Fantasy Foodball Pool, a first-of-its-kind free online game where players can create a lineup made entirely of their favorite food and drink combinations. No matter the plate – fantasy or real – TUMS provides fast relief when occasional heartburn strikes so fans can tackle unwanted sympto
WARREN, N.J., Dec. 2, 2024 /PRNewswire/ -- Haleon, a world-leading consumer health company, is pleased to announce the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for its US business, effective December 1, 2024. In this role, Joe will lead the organization's customer strategy, driving growth and transformation in the US market. Joe brings extensive leadership experience to the role, having spent over 20 years in the FMCG sector and serving in the military. Most recently Joe led Unilever's Walmart business, overseeing the company's largest US customer. In his
NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Haleon, a global leader in consumer healthcare, has chosen Vistar Media, the leading global provider of technology solutions for out-of-home (OOH) media, as its preferred partner for programmatic OOH across all key markets. Through this partnership, Vistar will collaborate with Publicis, Haleon's media agency, to power OOH campaigns worldwide—leveraging Vistar's advanced technology to maximize impact and media efficiency. As a globally renowned leader in consumer health, Haleon's decision to select Vistar as their preferred partner underscores the strategic importance of DOOH in their media strategy. By leveraging Vistar's industry-leading dem
The new campaign features Canadian NFL Player Chase Brown of the Cincinnati Bengals MISSISSAUGA, ON, Oct. 15, 2024 /CNW/ - Today, Advil proudly announced it is the official pain relief partner of the NFL in Canada. Recognizing that tough pain can slow anyone down, this partnership highlights the fast-acting relief of Advil alongside the excitement of the NFL. The campaign features Chase Brown, the speedy running back from London, Ontario, who plays for the Cincinnati Bengals. https://www.youtube.com/watch?v=bn5jduq2qNI "Advil is excited to bring this campaign to Canadians as we continue to help them tackle their pain" said Amrita Maharajh, Senior Brand Manager, Advil. The campaign will off
LONDON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- PubMatic (NASDAQ:PUBM), an independent technology company delivering digital advertising's supply chain of the future, today announced the launch of a new collaborative approach to supply path optimisation (SPO) for global healthcare company, Haleon. PubMatic has been selected by Haleon as a preferred supply partner to increase efficiency and streamline access to video, display, and connected TV (CTV) inventory globally, while also making media investments more sustainable. PubMatic provides transparent bidding technology and actively supports Haleon brands including Advil, Centrum, and Tums through programmatic media buys, thus maximising effici
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
BNP Paribas Exane upgraded Haleon plc from Neutral to Outperform and set a new price target of $13.40
Morgan Stanley upgraded Haleon plc from Equal-Weight to Overweight and set a new price target of $11.25
HSBC Securities downgraded Haleon plc from Buy to Hold
Morgan Stanley downgraded Haleon plc from Overweight to Equal-Weight
Bernstein downgraded Haleon plc from Outperform to Mkt Perform
Goldman downgraded Haleon plc from Buy to Neutral
Berenberg initiated coverage of Haleon plc with a rating of Buy
Berenberg initiated coverage of Haleon plc with a rating of Buy
HSBC Securities initiated coverage of Haleon plc with a rating of Buy
Jefferies resumed coverage of Haleon plc with a rating of Buy
Live finance-specific insights
BOSTON, June 3, 2024 /PRNewswire/ -- Yellow Wood Partners LLC ("Yellow Wood"), a Boston-based private equity firm known for investing in consumer brands and companies, is pleased to announce that its portfolio company, Suave Brands Company, has successfully completed the acquisition of the ChapStick brand from Haleon (NYSE:HLN). This transaction also results in Haleon becoming a shareholder in Suave Brands Company. Suave Brands Company Chief Executive Officer, Daniel Alter, said, "As we continue to build Suave Brands Company as the top independent North American beauty & personal care company by combining the agility of a start-up with the power of market leading brands, the addition of Cha
BOSTON, Jan. 25, 2024 /PRNewswire/ -- Yellow Wood Partners ("Yellow Wood"), a Boston-based private equity firm focused on investing in consumer brands and companies, today announced that its portfolio company Suave Brands Company has signed a binding offer to acquire the ChapStick brand from Haleon (NYSE:HLN), a global leader in consumer health. The transaction is intended to close in the first half of 2024 upon completion of customary closing and regulatory approvals. ChapStick invented the lip care category in the 1880s with the launch of a now-iconic lip balm that made ChapStick a household name. For more than a century, ChapStick has added products to its portfolio with innovative new i
Not for release, publication or distribution, directly or indirectly, in or into any jurisdiction into which such distribution would be unlawful. This notice is for informational purposes only and does not constitute an offer to purchase, or a solicitation of an offer to sell, any securities. The exchange offers referred to herein are being made solely pursuant to the Prospectus and related documents. The exchange offers referred to herein are not being made to holders of securities in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. LONDON, Oct. 31, 2022 /PRNewswire/ -- Haleon plc ("Haleon
This live feed shows all institutional transactions in real time.
SC 13G - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)
SC 13D/A - Haleon plc (0001900304) (Subject)